Xcout Intel
TreeFrog Therapeutics
TreeFrog Therapeutics is a French-based biotech company headquartered in Pessac, France. It aims to make iPS-derived cell therapies safer, more efficient, and more affordable to cure millions of patients.
Subscribe to see TreeFrog Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TreeFrog Therapeutics at a glance
TreeFrog Therapeutics is a biotech company headquartered in France. Xcout tracks 18 named people at TreeFrog Therapeutics, including Mark Rothera (Chief Executive Officer).
TreeFrog Therapeutics leadership
- Mark RotheraChief Executive Officer
- Michaël Lanero FidalgoChief Operating Officer
- François GianelliChief Regulatory & Quality Officer
- Jens SchröderChief Medical Officer
- Lauriane GillardChief Legal & IP Officer
- Myriam MakhloufiChief Strategy Officer
12 more named people on record for TreeFrog Therapeutics, with roles, board committees and tenure — see the full roster →
TreeFrog Therapeutics competitors
A few of TreeFrog Therapeutics's closest competitors — see the full list of competitors and alternatives →
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Kenai Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California. The company pioneers next-generation therapeutic approaches by leveraging induced pluripotent stem cell (iPSC) technology.
NutrigeneAI Biotech Limited is an iPSC cell therapy platform operating in Hong Kong. The company focuses on biotechnology research and development, maintaining pipeline therapies and regional office operations.
Ferring Ventures is a research company based in Kuopio, Finland, specializing in the translational field of cell therapy. The organization focuses on the discovery, establishment, and development of Advanced Therapy Medicinal Products (ATMPs) through Phase I and IIa clinical trials.
Get TreeFrog Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on TreeFrog Therapeutics in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access